Medication info
Double Pojijeong 10/160mg

Double Pojijeong 10/160mg

Prescription medicationTabletOral
Ingredient · strength
Valsartan›160mg / 1 tabletAmlodipine Besylate›13.87mg / 1 tablet
Manufacturer / importer
Joah Pharmaceutical Co., Ltd.
Appearance
Bright yellow rectangular film-coated tablet
Packaging
30 tablets/bottle
Approval status
Active

MFDS item code 201701483 · Approved 2017.03.29 · Insurance code 644603650

Summary

Main use
Treatment of essential hypertension not controlled by monotherapy
Who takes it
Adults · Children
Adult dose
The recommended dose of this medicine is 1 tablet once daily, taken with water, regardless of meals. It is recommended that it be taken at the same time each day, if possible (e.g., in the morning). Before starting this medicine, it is recommended that the dose be adjusted using the individual components (amlodipine or valsartan). However, if blood pressure is not adequately controlled with monotherapy using the individual components as described below, switching directly to this medicine may be considered. ㆍ5/80 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 80 mg monotherapy. ㆍ5/160 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 160 mg monotherapy. ㆍ10/160 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg or valsartan 160 mg monotherapy, or with 5/160 mg. Patients taking valsartan and amlodipine concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. Patients with renal impairment: No dose adjustment is required in patients with mild to moderate renal impairment (creatinine clearance 10mL/min or greater); however, this medicine should not be administered to patients with severe renal impairment (creatinine clearance less than 10mL/min) or patients on dialysis. In patients with moderate renal impairment, monitoring of potassium levels and creatinine is recommended. Patients with hepatic impairment: In patients with mild to moderate hepatic impairment, the daily dose of valsartan should not exceed 80mg. This medicine should not be administered to patients with severe hepatic impairment, biliary cirrhosis, biliary obstruction, or cholestasis. Patients aged 65 years or older: Use caution when increasing the dose.
Child dose
Pediatrics: The safety and efficacy of this drug have not been established in pediatric patients under 18 years of age; therefore, its use is not recommended.

Ingredients

Manufacturer
Joah Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of essential hypertension not controlled by monotherapy

  • Essential hypertension
View approved original text

This medication is used for patients with essential hypertension who have difficulty controlling blood pressure with either amlodipine or valsartan as monotherapy. It effectively lowers blood pressure, helping to reduce the risk of vascular complications such as those affecting the heart or brain. It contributes to stable blood pressure management for maintaining a healthy daily life.

How to take

Adult dose

The recommended dose of this medicine is 1 tablet once daily, taken with water, regardless of meals. It is recommended that it be taken at the same time each day, if possible (e.g., in the morning). Before starting this medicine, it is recommended that the dose be adjusted using the individual components (amlodipine or valsartan). However, if blood pressure is not adequately controlled with monotherapy using the individual components as described below, switching directly to this medicine may be considered. ㆍ5/80 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 80 mg monotherapy. ㆍ5/160 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 160 mg monotherapy. ㆍ10/160 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg or valsartan 160 mg monotherapy, or with 5/160 mg. Patients taking valsartan and amlodipine concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. Patients with renal impairment: No dose adjustment is required in patients with mild to moderate renal impairment (creatinine clearance 10mL/min or greater); however, this medicine should not be administered to patients with severe renal impairment (creatinine clearance less than 10mL/min) or patients on dialysis. In patients with moderate renal impairment, monitoring of potassium levels and creatinine is recommended. Patients with hepatic impairment: In patients with mild to moderate hepatic impairment, the daily dose of valsartan should not exceed 80mg. This medicine should not be administered to patients with severe hepatic impairment, biliary cirrhosis, biliary obstruction, or cholestasis. Patients aged 65 years or older: Use caution when increasing the dose.

Child dose

Pediatrics: The safety and efficacy of this drug have not been established in pediatric patients under 18 years of age; therefore, its use is not recommended.

Precautions

This medication can cause serious harm to the fetus and newborn if used in pregnant women during the second and third trimesters; therefore, it should be discontinued immediately if pregnancy is confirmed. Patients with allergies to this medication's ingredients, those who are pregnant or nursing, patients with severe kidney or liver diseases, and patients with specific cardiovascular diseases should not use this medication. Patients with sodium or fluid deficiency may experience hypotension, so their condition should be checked before administration, and careful monitoring is required. In patients with high potassium levels or those taking potassium-containing medications, potassium levels should be checked frequently. Use with caution in patients with renal artery stenosis, kidney transplant recipients, patients with a history of angioedema, heart failure, or those who have had a myocardial infarction, and blood pressure and kidney function should be monitored regularly. Caution is advised as dizziness or fatigue may occur when driving or operating machinery. This medication may interact with other antihypertensive medications, diuretics, heart medications, etc., so it is essential to inform your doctor or pharmacist of any other medications being taken. In elderly patients, the same dosage as for adults is recommended, but caution may be needed depending on the condition. Overdose can cause hypotension or heart rhythm abnormalities, so if suspected, a medical facility should be visited immediately. This medication is not recommended for children under 18 years of age due to insufficient evidence of safety and efficacy. If there are any abnormal symptoms or discomfort during administration, consult healthcare professionals immediately, and it is essential to regularly monitor blood pressure and kidney function.

Side effects

Nasopharyngitis, influenza, hypersensitivity, visual impairment, anxiety, headache, dizziness, drowsiness, orthostatic dizziness, paresthesia, vertigo, tinnitus, tachycardia, palpitations, syncope, orthostatic hypotension, hypotension, cough, throat and laryngeal pain, diarrhea, nausea, abdominal pain, constipation, dry mouth, rash, erythema, hyperhidrosis, pruritus, joint swelling, low back pain, arthritis, muscle cramps, lethargy, pollakiuria, polyuria, erectile dysfunction, edema, chemosis, facial edema, peripheral edema, fatigue, flushing, weakness, facial flushing, decreased hemoglobin, decreased hematocrit, neutropenia, thrombocytopenia, hypersensitivity including serum sickness, increased serum potassium, vasculitis, elevated liver function test results, angioedema, myalgia, renal failure, kidney damage, elevated serum creatinine, insomnia, decreased libido, pharyngitis, rhinitis, sinusitis, upper respiratory tract infection, viral infection, intestinal vascular edema, diplopia, thrombocytopenia, leukopenia, allergic reaction, hyperglycemia, insomnia, mood changes, tremors, sensory loss, taste disorder, peripheral neuropathy, hypertonia, arrhythmia, bradycardia, atrial fibrillation, ventricular tachycardia, myocardial infarction, vasculitis, dyspnea, rhinitis, vomiting, dyspepsia, pancreatitis, gastritis, gingival hyperplasia, hepatitis, jaundice, alopecia, purpura, skin depigmentation, phototoxic reaction, urticaria, erythema multiforme, Stevens-Johnson syndrome, myalgia, dysuria, nocturia, gynecomastia, pain, malaise, chest pain, weight loss, weight gain, increased liver enzymes, chest discomfort, abdominal discomfort, gastroesophageal reflux disease, neck pain, hypercholesterolemia, hypoglycemia, neurosensitization, Stevens-Johnson syndrome, chest pain, weight gain, arthralgia, skeletal pain, rhabdomyolysis, gingival hyperplasia, gastritis, neurosensitization, sensory loss

Not everyone experiences these, and they can vary from person to person.

Storage

Store this medication in a tightly closed container to protect it from air and moisture. The storage temperature should be between 1 degree and 30 degrees Celsius at room temperature.

Appearance and packaging

Appearance

Bright yellow rectangular film-coated tablet

Package unit

30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.